✦ LIBER ✦

Patterns of Diagnosis and Acute and Preventive Treatment for Migraine in the United States: Results from the American Migraine Prevalence and Prevention Study : CME

✍ Scribed by Seymour Diamond; Marcelo E. Bigal; Stephen Silberstein; Elizabeth Loder; Michael Reed; Richard B. Lipton

Book ID: 109099796
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 95 KB
Volume: 0
Category: Article
ISSN: 0017-8748
DOI: 10.1111/j.1526-4610.2006.00631.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic Burden of Transformed Migraine:

Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study

✍ Julie Munakata; Elisabeth Hazard; Daniel Serrano; David Klingman; Marcia F.T. Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Headache Impact of Chronic and Episodic

Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study

✍ Dawn Buse; Aubrey Manack; Daniel Serrano; Michael Reed; Sepideh Varon; Catherine 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

Rates and Predictors of Starting a Tript

Rates and Predictors of Starting a Triptan: Results From the American Migraine Prevalence and Prevention Study

✍ Marcelo E. Bigal; Dawn C. Buse; Ya-Ting Chen; Wendy Golden; Daniel Serrano; Min 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Prevalence, incidence, and treatments of

Prevalence, incidence, and treatments of Dupuytren’s disease in the United States: results from a population-based study

✍ Dana Britt DiBenedetti; Dat Nguyen; Laurie Zografos; Ryan Ziemiecki; Xiaolei Zho 📂 Article 📅 2010 🏛 Springer-Verlag,Elsevier Science 🌐 English ⚖ 199 KB

## Background This large population-based study was conducted to estimate the prevalence of Dupuytren’s disease in US adults and describe associated treatment patterns. ## Methods A total of 23,103 individuals from an Internet-based research panel representative of the US population completed a b

Zolmitriptan 5 mg Nasal Spray: Efficacy

Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine—Results From Phase 1 of the REALIZE Study

✍ Marek Gawel; Jürgen Aschoff; Arne May; Bruce R. Charlesworth; REALIZE Study Team 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Rizatriptan 5 mg for the Acute Treatment

Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: Results From a Double-Blind, Single-Attack Study and Two Open-Label, Multiple-Attack Studies

✍ W. Hester Visser; Paul Winner; Kim Strohmaier; Meghan Klipfel; Yahong Peng; Kath 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB